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In Saccharomyces cerevisiae UV radiation and a variety of chemical DNA-damaging agents induce the
transcription of specific genes, including several involved in DNA repair. One of the best characterized of these
genes is PHR1, which encodes the apoenzyme for DNA photolyase. Basal-level and damage-induced expression
of PHR1 require an upstream activation sequence, UASPHR1, which has homology with DRC elements found
upstream of at least 19 other DNA repair and DNA metabolism genes in yeast. Here we report the identification
of the UME6 gene of S. cerevisiae as a regulator of UASPHR1 activity. Multiple copies of UME6 stimulate
expression from UASPHR1 and the intact PHR1 gene. Surprisingly, the effect of deletion of UME6 is growth
phase dependent. In wild-type cells PHR1 is induced in late exponential phase, concomitant with the
initiation of glycogen accumulation that precedes the diauxic shift. Deletion of UME6 abolishes this
induction, decreases the steady-state concentration of photolyase molecules and PHR1 mRNA, and increases
the UV sensitivity of a rad2 mutant. Despite the fact that UASPHR1 does not contain the URS1 sequence, which
has been previously implicated in UME6-mediated transcriptional regulation, we find that Ume6p binds to
UASPHR1 with an affinity and a specificity similar to those seen for a URS1 site. Similar binding is also seen
for DRC elements from RAD2, RAD7, and RAD53, suggesting that UME6 contributes to the regulated expres-
sion of a subset of damage-responsive genes in yeast.
Cells respond to environmental stress by altering growth and
developmental programs to counteract the effects of the stress
and to ensure the survival of the cell or organism. These
changes reflect modulation of the specificity or activity of spe-
cific proteins as well as induction or repression of specific
genes. The cellular response to UV-induced stress is one of the
best characterized of these responses. In eukaryotes, UV ra-
diation and other DNA-damaging agents activate cell cycle
checkpoints and induce transcription of genes encoding pro-
teins involved in DNA repair and damage tolerance. These
processes are linked through one or more signal transduction
pathways, the components of which have been most extensively
characterized for Saccharomyces cerevisiae. In this organism
UV damage-responsive checkpoints can be activated in G1, S,
or G2 phase (reviewed in reference 41). While current evi-
dence suggests that the damage-sensing components may differ
(41), all three checkpoints, as well as the transcriptional re-
sponse, require the protein kinases encoded by MEC1 and
RAD53 (23, 41, 60). The Dun1 protein kinase, which functions
downstream of Mec1 and Rad53, is also required for the tran-
scriptional response of at least some damage-responsive genes
but is not required for cell cycle arrest (41, 72). Recently
another protein kinase, Hrr25, has been implicated in the
transcriptional response (18); however, the relationship of
this kinase to the Mec1-Rad53-Dun1 pathway remains un-
defined.
Identification of the transcriptional regulators that are the
ultimate targets of the damage signal transduction pathway is
crucial to understanding the mechanism of the damage re-
sponse. While more than 20 damage-inducible genes have
been described for S. cerevisiae, the transcription factors that
regulate expression of these genes are largely unknown. The
transcriptional activators Msn2 and Msn4, acting through the
stress-response element (STRE), control a group of genes that
respond to multiple stresses, including heat shock, osmotic
stress, nitrogen starvation, and oxidative stress (including oxi-
dative stress induced by agents that also damage DNA) (35,
49). However, the relevance of this induction to DNA damage
and repair is not clear, because none of the STRE-regulated
genes identified thus far play roles in DNA repair. The Swi4
and Swi6 transcription factors are required for induction of
RNR2 and RNR3 (which encode subunits of ribonucleotide
reductase) in response to methyl methanesulfonate or hy-
droxyurea; however, it is not known whether this reflects a
direct interaction with an RNR promoter element(s), nor have
the sequences required for Swi4/Swi6-mediated induction of
the RNR genes been identified (18). The 59 flanking regions of
at least 19 DNA repair and metabolism genes contain similar
sequence elements, known as DRC elements (47), and it has
been reported that the single-stranded-DNA-binding protein
replication protein A (RP-A) binds in vitro to oligonucleotides
containing similar elements from RAD1, RAD2, RAD4,
RAD10, RAD16, RAD51, RNR2, RNR3, PHR1, DDR48, MGT,
and MAG (55). However, an in vivo role for RP-A in the
transcriptional regulation of these genes has not been estab-
lished.
In this communication we report the cloning and identifica-
tion of a transcriptional regulator of the S. cerevisiae DNA
repair gene PHR1. PHR1 encodes the apoenzyme for the re-
pair enzyme DNA photolyase. This enzyme catalyzes the light-
dependent repair of cyclobutane-type pyrimidine dimers in
DNA and stimulates “dark repair” of these lesions via a mech-
anism that requires an active nucleotide excision repair path-
way (48). PHR1 transcription is induced by a variety of DNA-
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damaging agents, including 254-nm radiation, methylmethane
sulfonate, 4-nitroquinoline oxide, nitrosoguanidine, and cis-
platin (24, 50), but is not induced by heat shock or photoreac-
tivating light. Deletion and mutation analysis of PHR1 59 flank-
ing sequences has identified three regulatory elements that
contribute to basal-level and induced expression: a 22-bp pal-
indrome (URSPHR1) that is the binding site for the damage-
responsive repressor PRP, an upstream activation sequence
(UASPHR1) comprised of two DRC elements arranged as an
interrupted molecular palindrome, and a novel essential se-
quence (UESPHR1) which antagonizes repressor binding or
function (47, 51). UASPHR1 is required for constitutive and
high-level induced expression of PHR1 but does not appear to
be damage responsive, at least in the context of a heterologous
promoter. To further characterize the transcriptional regula-
tion of PHR1, we have carried out a screen for genes which,
when present in multiple copies, enhance expression from
UASPHR1. This screen has identified the transcriptional regu-
lator UME6 as a multicopy enhancer of PHR1 activity. Dele-
tion of UME6 has demonstrable effects on expression of PHR1
in the absence of DNA damage and on UV sensitivity and
photoreactivation. Evidence that these effects are the result of
direct interaction between UASPHR1 and Ume6 protein
(Ume6p) is presented. We also find that Ume6p binds specif-
ically to DRC elements from RAD2, RAD7, and RAD53, sug-
gesting that UME6 may be a common regulator of a group of
DNA repair genes.
MATERIALS AND METHODS
Oligonucleotides. The oligonucleotides used in this study are listed in Table 1.
Plasmids and plasmid constructions. Plasmid constructions and transforma-
tion of Escherichia coli were performed by standard techniques. Plasmid struc-
tures were confirmed by restriction endonuclease digestion patterns and, where
indicated, by DNA sequence analysis. Plasmids pBM1501, pPAL, pRS415,
pRS416, pGBS116, pMAL-UME6, YEp24, pHY14-2, and pHY16-2 and the
Carlson-Botstein Saccharomyces cerevisiae genomic library have been described
previously (3, 6, 11, 40, 47, 50, 54, 59). Plasmid pPRTCM was a gift from Howard
Fried (University of North Carolina at Chapel Hill); it is a CEN plasmid carrying
TRP1 and the TCM1-lacZ fusion from pTCMZ2 (15).
Plasmids containing HIS3 and lacZ reporter genes were generated as follows.
Plasmid pBM1501 carries the S. cerevisiae HIS3 gene, including the TATA box,
but lacks a functional UAS (11). pGBS287 (Fig. 1) was constructed by ligating
annealed DNA oligonucleotides RIUAStop and RIUASbot, which contain
UASPHR1, into the EcoRI site upstream of HIS3 in pBM1501, thereby placing
expression of HIS3 under the control of UASPHR1. The b-galactosidase reporter
plasmid pGBS501 (Fig. 1) was produced by ligating a 4-kbp SmaI-ScaI fragment,
containing the UASPHR1-CYC1-lacZ construct from pPAL (47) (Fig. 1), into
NaeI-SmaI-digested pRS415. pGBS203, pGBS204, pGBS205, and pGBS206 are
derivatives of pGBS501 and were constructed by ligation of various hybridized
oligonucleotides into pGBS501 which had been digested with SphI and PstI.
Each construction replaced the UASPHR1 fragment and approximately 250 bp of
vector sequence with either an intact or a mutated UASPHR1 element. Oligonu-
cleotides used in these constructions were P-DCGA-Stop and P-DCGA-Sbot for
pGBS203, P-PAL-Stop and P-PAL-Sbot for pGBS204, P-mCGA-Stop and P-
mCGA-Sbot for pGBS205, and P-mGAAG-Stop and P-mGAAG-Sbot for
pGBS206. The presence and orientation of UASPHR1 elements in each of the
above-described plasmids were confirmed by DNA sequencing.
pGBS503 (Fig. 1) was isolated during our library screen and is a YEp24
derivative containing ;4.5 kbp of S. cerevisiae genomic DNA inserted at the
unique BamHI site (6). The insert contains unique SphI and PvuII sites.
pGBS508 and pGBS510 (Fig. 2) are subclones derived from pGBS503 and were
constructed as follows. pGBS503 was digested with SphI, yielding 8.9- and 3.1-
TABLE 1. Oligonucleotides used in this study
Name Sequencea Sequence location (gene)b Reference
ACTtop 59-TCTATCGTCGGTCGACCAAGACAC-39 4053429
ACTbot 59-ATGGAAGATGGAGGCAAAGC-39 12829312619
pBRBAMcw 59-TACTTGGAGCCACTATCGACTACGCGATCA-39 373333762 (tet) 6
pBRBAMccw 59-TAGGCGCCAGCAACCGCACCTGT-39 38509338289 (tet) 6
DUG6PCR1 59-CCACTATCGACTACGAGATCTTGGCGACC-39 374233770 (tet) 6
DUG6ccw 59-TGCTCGTACCAGATCTGGTAGAAATTTGGCTTATCAGTACG-39 27649327409 (UME6) 59
RIUAStop 59-AATTCTTTTCTTCCTCGTTTTTCGAGGAAGCAG-39 21213293 (PHR1) 47





P-PAL-Stop 59-CTTTTCTTCCTCGTTTTTCGAGGAAGCAGTGCATG-39 212193293 (PHR1) 47







PHR347 59-ATGTCATCACTGCAGATGATTGGAGAG-39 3473373 46
PHR1266 59-TGCTACAGGGTTATTCTCCCATT-39 12669312449 46
SPO13top 59-AATTCGAAATAGCCGCCGACAAAAAGGAATTG-39 21013276 (SPO13) 4
SPO13bot 59-AATTCAATTCCTTTTTGTCGGCGGCTATTTCG-39 2769321019 (SPO13) 4
MAGURS2top 59-AATTCTCTTTTCGGTGGCGATGAATG-39 218032161 (MAG) 55, 68
MAGURS2bot 59-AATTCATTCATCGCCACCGAAAAGAG-39 21619321809 (MAG) 55, 68
RAD2top 59-AATTCGAACCTCCGTGGAGGCATTAAAAGGGAG-39 217732149 (RAD2) 31
RAD2bot 59-AATTCTCCCTTTTAATGCCTCCACGGAGGTTCG-39 2149931779 (RAD2) 31
RAD7top 59-AATTCTTATTTATGGAAGCAAAAATGGAATAAAG-39 212932101 (RAD7) 43
RAD7bot 59-AATTCTTTATTCCATTTTTGCTTCCATAAATAAG-39 21019321299 (RAD7) 43
RAD53top 59-AATTCATCACCGTGGGTAGACTTGGAAATG-39 223732211 (RAD53) 71
RAD53bot 59-AATTCATTTCCAAGTCTACCCACGGTGATG-39 22119322369 (RAD53) 71
a Underlined bases were added to introduce restriction sites or complementary ends for cloning.
b Numbers refer to locations relative to the translational start site of the gene in the reference given. Primes indicate sequence on the noncoding strand.
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kbp fragments. Self-ligation of the 8.9-kbp fragment yielded pGBS508, and
ligation of the 3.1-kbp fragment into YEp24 digested with SphI yielded
pGBS510. To construct pGBS512 and pGBS514 (Fig. 2), pGBS503 was digested
with PvuII, yielding fragments of 8.7 and 3.2 kbp. Self-ligation of the 8.7-kbp
fragment produced pGBS512, and ligation of the 3.2-kbp fragment into YEp24
digested with PvuII produced pGBS514. PCR was used to amplify the UME6
sequence from pGBS503 by using the primers DUG6PCR1 and DUG6ccw; the
amplified fragment was digested with BglII and inserted into the BamHI site of
YEp24, yielding pGBS520 (Fig. 2). Insertion of a 4.2-kbp HindIII fragment,
containing the entire yeast genomic insert from pGBS503, into HindIII-digested
pUC19 yielded pGBS516. To construct the UME6 knockout plasmid pGBS517,
the LEU2 gene in pRS415 was amplified by PCR with primers that added unique
BssHII and MluI sites immediately 59 and 39 to the gene. This fragment was
ligated into BssHII-MluI-digested pGBS516, thereby replacing the 2.4-kbp
BssHII-MluI fragment of UME6 (59) with LEU2.
Yeast culture. Yeast strains were routinely propagated at 30°C in yeast extract-
peptone-adenine-dextrose (YPAD) or synthetic complete medium (SC) lacking
Trp, Ura, His, or Leu as previously described (47). Library screen plates (SC
lacking His, Leu, and Ura) also contained 3-amino-1,2,4-triazole (3AT) (Sigma
Chemical Company) at a concentration of 20 mM. ura3 mutants or strains that
had lost URA3-containing plasmids were selected by growth on 5-fluoroorotic
acid (American Biorganics) agar.
Yeast strains. All yeast strains used in this study are listed in Table 2. Inte-
gration of pGBS287 adjacent to the genomic LYS2 gene of RE1007 was directed
by cutting the plasmid at a unique PvuII site within LYS2 39 flanking sequences
(11), yielding strain GBS149. Integration was confirmed by Southern analysis of
genomic DNA, mitotic stability of the URA3 marker under nonselective growth
conditions, and growth of GBS149 on SC lacking His. Strain GBS153 is a
derivative of GBS149 which lost the integrated URA3 sequences via intrachro-
mosomal homologous recombination between sequences 39 to LYS2 but retained
the UASPHR1-HIS3 reporter gene. The library screen strain GBS242 was con-
structed by transforming pGBS501 into GBS153. GBS783 is a derivative of
GBS153 containing pRS415. GBS118 is isogenic to the previously described
strain GBS117, in which the genomic PHR1 locus has been replaced by a PHR1-
lacZ fusion gene (50). 5-Fluoroorotic acid selection for spontaneous mutations
inactivating URA3 in GBS118 yielded GBS231. Strains GBS238 and GBS239 are
independent isolates from a transformation of pGBS503 into GBS231. Strains
GBS235 and GBS236 were obtained by curing GBS238 of pGBS503, and
GBS237 was isolated by curing GBS239 of pGBS503. Strains GBS1001,
GBS1002, GBS1003, GBS1061, GBS1063, GBS1330, GBS1333, GBS1336,
GBS1339, GBS1351, GBS1353, GBS1358, and GBS1361 are transformed deriv-
atives of yC105 (59) and contain the plasmids indicated in Table 2. Strain
GBS1072, in which UME6 is replaced by LEU2, was generated by transforming
GBS77 with pGBS518 digested with BamHI and HindIII.
UV survival. Late-log-phase cultures (A600 5 1.0; ;107 cells/ml) grown in
liquid SC lacking Ura were harvested by centrifugation, washed in phosphate-
buffered saline, suspended, and irradiated at 254 nm as previously described (48).
Photoreactivation was carried out under the same conditions as 254-nm irradi-
ation except that a BLB black lamp was used, the fluence rate was 0.9 J/m2/s, and
the photoreactivation period was limited to 5 min. Repair of pyrimidine dimers
by photolyase nullifies the lethal effects of a portion of the UV dose. The dose
decrement, DD, is defined as the difference between the UV doses with and
without photoreactivation that yield the same surviving fraction (17). The num-
ber of pyrimidine dimers repaired was obtained by multiplying DD by the number
of dimers introduced per haploid genome per joule per square meter, which has
been estimated as 240 (65).
Glycogen determination. Samples (50 to 100 ml) were collected from log-
phase cultures of GBS1001 and GBS1002 grown in SC lacking Ura. Cells were
pelleted by centrifugation at 2,000 3 g at 4°C for 10 min, washed once with
ice-cold water, pelleted, suspended in 0.5 ml of 0.25 M Na2CO3, and stored at
270°C. Conversion of glycogen to glucose and assays of glucose concentration
were performed as described by Francois et al. (12) and Skroch (56) with the
following modifications: 5 ml of enzyme color reagent (Diagnostics Procedure
510; Sigma Chemical Company) was added to 0.5 ml of cleared lysate, and the
mixture was incubated at 37°C for 30 min. Glucose concentrations were deter-
mined by A440 with reference to a glucose standard curve.
Library screen. A YEp24-based yeast genomic library (6), previously amplified
once, was purified from E. coli and transformed into GBS242. Transformed cells
were plated onto Hybond N filters (Amersham), overlaid onto plates containing
SC lacking Leu and Ura, and incubated at 30°C for 18 to 24 h, at which time the
filters were transferred to screen medium plates (SC lacking Leu, Ura, and His
and containing 20 mM 3AT) and incubated for 7 more days. Prolonged incuba-
tion was necessary due to slow growth on the screen medium. After 7 days, the
nylon filters were lifted, frozen in liquid nitrogen for 1 min, and placed on filter
paper (Whatmann no. 1) soaked in b-galactosidase assay solution (5 ml of Z
buffer [37], 39 mM b-mercaptoethanol, 334 mg of 5-bromo-4-chloro-3-indolyl-b-
D-galactopyranoside per ml). The filters were incubated at 30°C for 2 to 4 h and
examined for colonies that turned blue faster than similarly treated control
colonies of GBS783 and GBS242. Four independent colonies from each positive
clone were recovered and retested. Plasmids from clones that displayed a positive
phenotype upon retesting were recovered by transformation into E. coli; plasmid
DNA was isolated and used to transform naive GBS242, looking for correlation
between survival on screen medium and survival on SC lacking Leu and Ura.
Southern and Northern analyses. Primers pBRBAMcw and pBRBAMccw
were used in PCR to obtain full-length copies of the yeast genomic inserts from
pGBS503 and pGBS504. PCRs were by standard techniques with the addition of
Taq Extender (as specified by the manufacturer [Stratagene]) to aid amplifica-
tion of the long template. PCR products were purified (PCR Cleanup Kit;
Promega), labeled (ECL Direct Nucleic Acid Labeling System; Amersham), and
used as probes in Southern analysis of EcoRI-digested DNAs from pGBS503 to
pGBS507.
For Northern analysis of PHR1 mRNA, 50 mg of total RNA, extracted from
early-log-phase (A600 5 0.1 to 0.2) or late-log-phase (A600 5 1.2 to 1.5) cultures
of GBS1001 and GBS1002, was electrophoresed through 1.2% agarose gels
containing 2.2 M formaldehyde and transferred to GeneScreen Plus nylon mem-
FIG. 1. Reporter plasmids used in this study. pGBS501 and pGBS503 are S.
cerevisiae-E. coli shuttle vectors. pGBS287 is a yeast integrating plasmid with
integration directed to a region 39 to LYS2, as described in Materials and
Methods. Open boxes indicate either UASPHR1 inserted upstream of the indi-
cated reporter gene or the S. cerevisiae chromosomal insert carrying UME6, as
labeled. The location of the UME6 coding sequence and direction of transcrip-
tion are indicated by the curved arrow. Gray box, lacZ coding sequences. Black
boxes, relevant E. coli and S. cerevisiae genetic elements with names indicated.
FIG. 2. Deletion analysis of the yeast genomic fragment carried by pGBS503.
The genomic fragment carried by pGBS503 is shown as a box, with the limits of
the UME6 coding sequence and direction of transcription indicated. Gray boxes
indicate yeast genomic sequences 59 and 39 to the UME6 coding sequence. The
extent of the genomic fragment remaining in each deletion construct is indicated
by the black and gray boxes. The percentage of ATr transformants was deter-
mined by transforming naive GBS242 with each plasmid and selecting separately
for Ura1 transformants and ATr transformants. Control transformations with
YEp24 yielded 4% ATr transformants; this value has been subtracted from the
values shown.
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branes as previously described (20). Probes for PHR1 and ACT1 mRNAs were
obtained by PCR amplification of specific regions of these genes from S288C
genomic DNA by using oligonucleotides PHR347, PHR1266, ACT1top, and
ACT1bot (Table 1). The purified fragments were labeled by the random hexamer
priming method with [32P]dCTP and were hybridized to the Northern blots.
Hybridized counts per minute were quantitated with a Molecular Dynamics
PhosphoImager.
Liquid b-galactosidase assays. Plasmid-containing strains were grown in liq-
uid medium, and 1.0- to 1.5-ml samples were collected in triplicate, pelleted by
centrifugation at 12,000 3 g for 10 min at 4°C, washed with 1.5 ml of Z buffer,
and repelleted. The Z buffer was removed, and cell pellets were frozen at 280°C.
For strains GBS235 to GBS240, in which the lacZ reporter construct is integrated
into the genome, 50-ml samples were collected. For the assay, cell pellets were
thawed at room temperature for 3 to 5 min, suspended in 100 ml of assay reagent
(Z buffer containing 43 mM b-mercaptoethanol, 0.2 mM phenylmethylsulfonyl
fluoride, 10 mg of apoprotinin per ml, 10 mg of soybean trypsin inhibitor per ml,
4 mg of leupeptin per ml, and 520 mg of Zymolyase T100 per ml), and incubated
at 35°C for 1.5 to 2 h. At the end of the incubation period, the cells were vortexed
vigorously for 45 s and immediately placed on ice. Forty microliters of the cell
lysate was added to 160 ml of reaction cocktail (12 mM b-mercaptoethanol, 50 ml
of 100 mg of 4-methylumbelliferyl-b-D-galactoside per ml, 25 mM Tris [pH 7.5],
125 mM NaCl, 2 mM MgCl2) and placed immediately at 37°C. After a 30-min
incubation, the reaction was stopped by addition of 50 ml of ice-cold 25%
trichloroacetic acid. The tubes were chilled on ice for at least 10 min and then
spun in a microcentrifuge at full speed for 4 min immediately prior to fluores-
cence determination. One hundred microliters of sample supernatant was added
to 1.9 ml of glycine carbonate buffer (133 mM glycine, 83 mM Na2CO3, pH 10.7),
and the fluorescence of the product, 4-methylumbelliferon, was determined in a
TKO 100 minifluorometer (Hoefer) (excitation wavelength 5 365 nm; emission
wavelength 5 460 nm). One unit of b-galactosidase activity is defined as 1 pmol
of 4-methylumbelliferon produced per ml of culture per A600 unit of cells in a
30-min assay. Each strain was tested on at least two different occasions.
Ume6 protein expression and purification. Maltose binding protein (MBP)-
Ume6 fusion protein was obtained by isopropylthio-b-D-galactoside induction
(0.3 mM for 2 h) of pMAL-Ume6 in E. coli CAG456 grown at 30°C (59),
followed by cell lysis and maltose affinity chromatography according to the
manufacturer’s instructions (Protein Fusion and Purification System; New En-
gland Biolabs). The MBP-Ume6 protein obtained in this manner was estimated
to be ;30% pure by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
followed by staining with Coomassie blue. The major contaminant migrated with
MBP.
Electrophoretic mobility shift assays. Probes for electrophoretic mobility
shift assays were made by hybridizing the complementary oligonucleotide
pairs RIUAStop-RIUASbot, MIXUAS1-MIXUAS2, MIXUAS1-EcoRI–
MIXUAS2-EcoRI, SPO13top-SPO13bot, MAGURS2top-MAGURS2bot,
RAD2top-RAD2bot, RAD7top-RAD7bot, and RAD53top-RAD53bot. Five mi-
crograms of each oligonucleotide was mixed in a final volume of 100 ml of 200
mM NaCl, heated to 95°C for 5 min, and then allowed to slowly cool to room
temperature. Probes were labeled with [a-32P]dATP (800 Ci/mmol; Amersham)
by using Klenow enzyme. The labeled probes were purified (NucTrap columns;
Stratagene), followed by extraction with phenol-chloroform and ethanol precip-
itation. Recoveries and specific activities of labeled probes were determined by
electrophoresis of aliquots on 6% nondenaturing polyacrylamide gels followed
by quantitation of radioactivity with an Ambis Radioanalytic Imaging System.
Protein binding reactions were carried out for 15 min at room temperature in
20-ml volumes containing binding buffer (4 mM Tris [pH 8.0], 4 mM MgCl2, 40
mM NaCl), 10 mg of apoprotinin per ml, 10 mg of soybean trypsin inhibitor per
ml, 4 mg of leupeptin per ml, 10% glycerol, 100 mg of bovine serum albumin per
ml, 5 mM dithiothreitol, and 5 mM phenylmethylsulfonyl fluoride; the MBP-
Ume6 protein, probe, and competitor were at the concentrations indicated in the
figure legends. For MBP control reactions, 260 nM purified MBP (a gift from
Aziz Sancar) was used. Bound and free probe were separated on 6% nondena-
turing polyacrylamide gels electrophoresed at 150 V for 2.75 h. Gels were dried,
and radioactivity was quantified with an Ambis Radioanalytic Imaging System.
Bound material was designated as all counts in material migrating slower than
the free probe band after subtraction of background counts in the “bound”
region of the MBP control lane (generally ,10% of total counts).
RESULTS
Cloning of UME6 as a multicopy enhancer of UASPHR1 ac-
tivity. UASPHR1 retains its function in the context of heterol-
ogous promoters (47). This permitted us to devise a selection
scheme for genes that, when present in multiple copies, en-
hance expression from UASPHR1. The strain used to screen for
such genes, GBS242, contained two reporter genes: an inte-
grated chimeric gene, UASPHR1-HIS3, in which HIS3 expres-
sion is driven from UASPHR1, and a UASPHR1-CYC1-lacZ gene
carried on the CEN plasmid pGBS501. Unlike the parental
TABLE 2. S. cerevisiae strains used in this study
Strain Genotypea Source or reference
GBS77 a rad2 leu2-3,112 ura3-52 50
GBS118 a PHR1-lacZ-URA3 leu2-3,112 trp1 ura3-52 50
GBS149 a can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-52 LYS2::UASPHR1-HIS3-URA3 This work
GBS153 a can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-52 LYS2::UASPHR1-HIS3 This work
GBS231 a PHR1-lacZ-ura3 leu2-3,112 trp1 ura3-52 This work
GBS235 GBS238 cured of pGBS503 This work
GBS236 GBS238 cured of pGBS503 This work
GBS237 GBS239 cured of pGBS503 This work
GBS238 Isogenic to GBS231 (pGBS503) This work
GBS239 Isogenic to GBS231 (pGBS503) This work
GBS242 Isogenic to GBS153 (pGBS501) This work
GBS783 Isogenic to GBS153 (pRS415) This work
GBS1001 Isogenic to yC105 (pGBS501 and YEp24) This work
GBS1002 Isogenic to yC105 (pGBS501 and pHY14-2) This work
GBS1003 Isogenic to yC105 (pGBS501 and pHY16-2) This work
GBS1061 Isogenic to yC105 (pPRTCM and YEp24) This work
GBS1063 Isogenic to yC105 (pPRTCM and HY16-2) This work
GBS1072 a Dume6::LEU2 rad2 leu2-3,112 ura3-52 This work
GBS1330 Isogenic to yC105 (pGBS204 and pHY14-2) This work
GBS1333 Isogenic to yC105 (pGBS203 and pHY14-2) This work
GBS1336 Isogenic to yC105 (pGBS205 and pHY14-2) This work
GBS1339 Isogenic to yC105 (pGBS206 and pHY14-2) This work
GBS1351 Isogenic to yC105 (pGBS203 and YEp24) This work
GBS1353 Isogenic to yC105 (pGBS204 and YEp24) This work
GBS1358 Isogenic to yC105 (pGBS205 and YEp24) This work
GBS1361 Isogenic to yC105 (pGBS206 and YEp24) This work
RE1007 a can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-52 M. Johnston
yC105 a ade2-1 ade6 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ume6-D1 59
a Plasmids carried by strains are indicated in parentheses.
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strain R1007, GBS242 grew in the absence of exogenous his-
tidine, confirming that UASPHR1 functions in the context of the
HIS3 promoter. GBS242 was transformed with an S. cerevisiae
genomic library constructed in the multicopy plasmid YEp24
(6), and Ura1 transformants carrying genes that enhanced
expression from UASPHR1 were selected by virtue of their
ability to grow on 20 mM 3AT, a competitive inhibitor of the
HIS3 gene product. Ura1 3ATr clones were then tested for
enhanced expression of the UASPHR1-CYC1-lacZ reporter.
Thirty-two clones positive in both tests were initially identified
among 17,700 Ura1 transformants. Following plasmid rescue
in E. coli and transformation into naive GBS242, library plas-
mids from five clones (pGBS503 to pGBS507) retained the
ability to confer the 3ATr phenotype in .60% of Ura1 trans-
formants. (The frequency of 3ATr clones presumably reflects a
threshold of HIS3 expression reached in only a subpopulation
of transformants carrying multiple copies of the plasmid.) Re-
striction analysis of these plasmids indicated that each con-
tained an ;4.5-kbp insert of yeast genomic DNA that con-
tained two EcoRI sites separated by 2.4 kbp. Southern analysis
of EcoRI-digested plasmid DNA revealed that the genomic
inserts from pGBS503 and pGBS504 hybridized strongly to
each of the five plasmids but not to YEp24 alone (data not
shown). We concluded that all five plasmids contain the same
genomic insert and limited further characterization to the li-
brary clone pGBS503.
Using primers PBRBAMcw and PBRBAMccw, which hy-
bridize, respectively, to tet sequences upstream and down-
stream of the cloned DNA fragment, we determined the nu-
cleotide sequence of ;250 bp from each end of the genomic
insert and compared these to S. cerevisiae sequences in the
GenBank and S. cerevisiae genomic databases. A 100% match
was obtained between the 39 160 bp primed from PBRBAMcw
and sequences 2841 to 2681 from the published 59 flanking
region of the bifunctional transcriptional regulator UME6 (59).
Likewise, a 100% match was found to 65 bp primed from
PBRBAMCCW and sequences within the 39 end of
YDR206W, an open reading frame of unknown function that
resides adjacent to the 39 end of UME6 on chromosome IV (7).
The presence of the entire UME6 gene was confirmed by
digestion of pGBS503 with a battery of restriction enzymes
that span the complete UME6 coding region as well as 841 bp
of 59 flanking region and 522 bp of 39 flanking sequences (59).
To confirm that UME6 is responsible for enhanced expression
from UASPHR1, we introduced subclones of pGBS503 that
contained various portions of the genomic insert into naive
GBS242. As can be seen in Fig. 2, only plasmid pGBS520,
which contains the entire UME6 coding region and 59 flanking
sequence and 258 bp of 39 flanking sequence, conferred a level
of 3AT resistance comparable to that seen with the library
plasmid pGBS503.
Multiple copies of UME6 enhance expression of PHR1 in its
normal chromosomal context. Expression of PHR1 is governed
by three upstream regulatory elements which lie in close prox-
imity within the PHR1 59 regulatory region (47). An important
question is whether by removing UASPHR1 from its native
context, we altered its regulatory properties either by eliminat-
ing interactions between proteins bound to contiguous pro-
moter elements or by fortuitously introducing a new regulatory
site during construction of the reporter genes. To address this
question, we introduced pGBS503 (UME6) into strain
GBS231, in which the chromosomal copy of PHR1 has been
replaced by an integrated PHR1-lacZ translational fusion (50).
b-Galactosidase activities in two transformed isolates (GBS238
and GBS239) was compared to those seen in isogenic deriva-
tives which had lost pGBS503 (GBS235, GBS236, and
GBS237). As can be seen in Table 3, multiple copies of UME6
stimulated expression of the PHR1-lacZ reporter three- to
fivefold in early-log-phase cultures.
Effects of a UME6 deletion on vegetative expression of
PHR1. Is the effect of UME6 on PHR1 expression limited to the
nonphysiological condition in which UME6 is overexpressed?
To address this question, we compared expression driven by
UASPHR1 in log-phase vegetative cells from strain GBS1001,
which carries a deletion of the entire UME6 coding sequence,
with that seen in GBS1002, which carries UME6 on a CEN
vector present in one or two copies per cell. PHR1 expression
is influenced by the stage of the growth cycle (25). Early in log
phase in glucose-containing media, PHR1 is expressed at a
constant level, while in late log phase expression increases five-
to sevenfold. This behavior is recapitulated in strains carrying
the UASPHR1-lacZ reporter plasmid pGBS501 (Fig. 3). The
onset of enhanced PHR1 expression appears to coincide with
the onset of glycogen accumulation (Fig. 3B) that immediately
precedes the switch from fermentative to oxidative metabolism
known as the diauxic shift (27). Deletion of UME6 altered two
features of this expression pattern. First, as can be seen in
Table 3 and Fig. 3B (compare strains GBS1001 and GBS1002),






genotype (copy no.) Reporter (location)





GBS238 UME6 UME6 (multicopy) PHR1-lacZ (chromosome) 54 6 6 NDb
GBS235 UME6 No plasmid PHR1-lacZ (chromosome) 10 6 1 ND
GBS236 UME6 No plasmid PHR1-lacZ (chromosome) 12 6 1 ND
GBS239 UME6 UME6 (multicopy) PHR1-lacZ (chromosome) 37 6 5 ND
GBS237 UME6 No plasmid PHR1-lacZ (chromosome) 11 6 2 ND
GBS1001 Dume6 YEp24 (multicopy) UASPHR1-lacZ (CEN plasmid) 840 6 170 850 6 120
GBS1002 Dume6 UME6 (1–2) UASPHR1-lacZ (CEN plasmid) 1,660 6 320 5,630 6 1,450
GBS1003 Dume6 rim16-12 (1–2) UASPHR1-lacZ (CEN plasmid) 1,250 6 260 4,050 6 660
GBS1061 Dume6 YEp24 (multicopy) TCM1-lacZ (CEN plasmid) 344,600 6 41,000 39,700 6 3,200
GBS1063 Dume6 UME6 (1–2) TCM1-lacZ (CEN plasmid) 244,300 6 21,300 42,711 6 2,700
a Means 6 standard deviations.
b ND, not determined.
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levels of the fusion protein in early log phase were reduced by
approximately 50% in the Dume6 background. While this effect
is small, it is entirely reproducible and has been seen in each of
four independent isolates of each genotype. Second, deletion
of UME6 abolished the enhanced accumulation of the fusion
protein in late log phase. To determine whether these changes
reflect events at the intact PHR1 promoter in its normal chro-
mosomal location, we performed Northern analysis of PHR1
mRNA from early-log-phase and late-log-phase cultures of
GBS1001 and GBS1002. As we have reported previously and is
apparent in Fig. 4, the steady-state concentration of PHR1
mRNA in early-log-phase cells is extremely low (50), and this
level is diminished approximately 40% in the absence of a
functional UME6 gene (compare lanes 1 and 3). Consistent
with the studies using the lacZ reporter plasmid, the steady-
state concentration of PHR1 mRNA increased dramatically
(approximately 15-fold) in late-log-phase cells, and this in-
crease was dependent upon the presence of an active UME6
gene (compare lanes 2 and 4 of Fig. 4). Two observations
indicate that these effects are specific for PHR1 rather than the
consequence of a general pleiotropic effect on gene expression:
(i) accumulation of most individual mRNA species decreases
or is unchanged in late log phase (reviewed in reference 67;
also see the ACT1 control in Fig. 4), and (ii) as can be seen in
Table 3 (compare GBS1061 and GBS1063), deletion of UME6
did not alter the expression pattern exhibited by the house-
keeping gene TCM1, which encodes the ribosomal protein L3.
Thus, UME6 plays a specific, dual role in PHR1 expression.
UME6 enhances basal-level expression of PHR1 during the
fermentative stage of cell growth, and UME6 is required for
PHR1 induction immediately preceding the diauxic shift.
Although it was initially identified as a repressor of vegeta-
tive expression of early meiotic genes (58), UME6 also plays a
role in the meiotic activation of some of these genes (3, 45).
Activation is achieved through interaction between Ume6p
and the transcriptional activator Ime1p at a cis-acting regula-
tory site known as URS1. URS1 is thought to be the binding
site for Ume6p or a complex containing Ume6p (39, 45, 57,
59). In a/a diploids, starvation for nitrogen and glucose leads
to activation of Ime1p, recruitment of Ime1p to the URS1 site
through interaction with Ume6p, and transcriptional activation
of the early meiotic genes (3, 39, 45). Although IME1 mRNA
is present at very low levels during vegetative growth (22), the
fact that IME1 expression is regulated in response to cyclic
AMP (cAMP) levels (36) suggested to us that Ime1p might
contribute to the enhanced expression of PHR1 seen during
the diauxic shift. We tested this hypothesis by using a UME6
allele known as rim16-12; the protein encoded by rim16-12
retains the ability to repress early meiotic genes during vege-
tative growth but is defective in Ime1p-mediated transcrip-
tional activation (3). As can be seen in Table 3, strain
GBS1003, which carries a deletion of UME6 and the rim16-12
allele on a CEN plasmid, supported a 3.2-fold induction of the
reporter in late log phase, compared to a 3.4-fold induction
with the wild-type UME6 gene. These results suggest that in-
teraction between Ume6p and Ime1p is not required for in-
duction of UASPHR1 at the diauxic shift in haploid vegetative
cells.
Ume6p binds specifically to UASPHR1. Genetic evidence in-
dicates that the bifunctional transcriptional regulatory se-
quence URS1 (consensus sequence, AGCCGCCGA [30]) is a
site of UME6 action (39, 42, 45, 57, 59, 61), and both full-length
Ume6p and an MBP-Ume6p fusion protein containing amino
acids 560 to 836 bind to URS1 in vitro (1, 59). The sequence of
UASPHR1, TTTTCTTCCTCGTTTTTCGAGGAAGCAGT,
does not contain a good match to the URS1 consensus (see
Fig. 6B), suggesting that the effect of UME6 on PHR1 expres-
sion might be mediated through another UME6-regulated pro-
FIG. 3. Effect of a deletion of UME6 on cell growth and expression from
UASPHR1. Cultures of strains GBS1001 (Dume6) and GBS1002 (UME6) growing
in liquid media were monitored for growth and expression from UASPHR1-lacZ
as described in Materials and Methods. (A) Growth of the cultures monitored by
A600. (B) Expression from UASPHR1-lacZ (E and ‚) and glycogen accumulation
in strain GBS1002 (h). Error bars indicate standard deviations from two to four
independent b-galactosidase or glycogen assays.
FIG. 4. Northern analysis of PHR1 mRNA levels in the presence or absence
of UME6. Total RNA was extracted from early-log-phase cultures (lanes 1 and
3) and late-log-phase cultures (lanes 2 and 4) of GBS1001 (Dume6) and
GBS1002 (UME6), separated, and probed as described in Materials and Meth-
ods. Hybridization to mRNA from the ACT1 gene served as an internal loading
control. Autoradiograms of the electrophoretic mobility shift assay gels were
scanned with a UMAX UC840 flat-bed scanner; the image was imported into
Adobe Photoshop for labeling and output.
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tein rather than through physical interaction of Ume6p with
UASPHR1. To test this possibility, we utilized the electro-
phoretic mobility shift assay to assess the binding of the MBP-
Ume6p fusion protein constructed by Stritch and coworkers
(59) to UASPHR1.
The MBP-Ume6p fusion protein formed a major complex
and a minor complex with the UASPHR1 oligonucleotide
RIUAS (Fig. 5A). Binding of Ume6p in the major complex was
specific as judged by the difference in response to increasing
concentrations of unlabeled homologous versus heterologous
(MIXUAS) competitor. A 10-fold molar excess of unlabeled
RIUAS reduced formation of the major labeled complex by
80%, while the same concentration of unlabeled MIXUAS
reduced complex formation by only 20% (Fig. 5A, lanes 7 and
13). In contrast, formation of the minor complex was largely
unaffected by addition of up to a 50-fold molar excess of
homologous or nonspecific competitor (Fig. 5A, lanes 8 and
14), suggesting that this complex reflects nonspecific interac-
tion with MBP-Ume6p.
In view of the absence of a URS1 consensus sequence in
UASPHR1, it was of interest to compare the affinity of Ume6p
for UASPHR1 to that for an extensively characterized UME6-
responsive regulatory sequence containing URS1. The SPO13
URS1 element was chosen for this comparison (59). MBP-
Ume6p displayed a slightly higher affinity for the SPO13 URS1
oligonucleotide than for the RIUAS oligonucleotide (compare
lanes 3 in Fig. 5A and B). At equimolar substrate and MBP-
Ume6p concentrations approximately 55% of the SPO13
URS1 oligonucleotide was bound, compared to 30% of the
RIUAS oligonucleotide. A 10-fold excess of homologous com-
petitor reduced MBP-Ume6p binding to labeled SPO13 URS1
by 60%, while the same concentration of nonspecific compet-
itor reduced binding by 20%. Based on these data and direct
titration experiments (data not shown), we estimate that the
equilibrium association constants (KAs) for MBP-Ume6p bind-
ing to the oligonucleotides are 2.0 (60.4) 3 107 M21 for
SPO13 URS1, 1.29 (60.14) 3 107 M21 for RIUAS, and
1.08 (60.4) 3 106 M21 for MIXUAS. Thus, the affinities and
specificities of MBP-Ume6p binding to UASPHR1 and to
SPO13 URS1 are similar.
Ume6 binds to other DRC elements from yeast. The 59
flanking regions of at least 19 yeast genes involved in DNA
repair and damage tolerance contain a sequence element
known as DRC which has the consensus sequence G/CGA/
TGGA/CRRNANA/T (47). UASPHR1 consists of an inter-
rupted palindrome comprised of two DRC elements flanking
five T’s. DRC elements are also found upstream of the dam-
age-responsive genes RAD2, RAD7, RAD16, RAD23, RAD53
(also known as SPK1 and MEC2), and MAG. In the cases of
RAD2 (53), RAD23 (44a), RAD53 (cited in reference 68),
MAG (68), and PHR1 (47), regions containing the DRC ele-
ments have been shown to be involved in regulated expression
of the genes. Does Ume6p recognize DRC elements from
genes other than PHR1? As can be seen in Fig. 6A, oligonu-
cleotides containing single DRC elements from MAG URS2,
RAD2, RAD7, and RAD53 form complexes with MBP-Ume6p.
Quantitation of the fraction of Ume6p-bound probe revealed
that the extent of complex formation for each of these DRC
elements was similar to that seen with UASPHR1 and SPO13
URS1: RIUAS, 29% (Fig. 6A, lane 2); SPO13 URS1, 40%
(lane 6); MAG URS2, 22% (lane 10); RAD2, 27% (lane 15);
RAD7, 35% (lane 19); and RAD53, 26% (lane 24). Further-
more, the responses of DRC elements from RAD2, RAD7, and
RAD53 to homologous and heterologous competitors paral-
leled those seen with RIUAS and SPO13 URS1. The compe-
tition results shown in Fig. 6 are presented quantitatively in
Table 4, from which it can be seen that a 3-fold excess of
homologous competitor and a 15-fold excess of nonspecific
competitor (MIXUAS) reduced binding to approximately sim-
ilar extents for SPO13 URS1 and the DRC elements from
UASPHR1, RAD2, RAD7, and RAD53. The DRC element from
MAG URS2 was exceptional in that a threefold excess of
homologous or heterologous competitor reduced binding to
similar extents, suggesting that MBP-Ume6p does not discrim-
inate well between MAG URS2 and the nonspecific competi-
tor. This is surprising considering that MAG URS2 is the best
match to the URS1 consensus among the elements tested (Fig.
6B).
The number of DNA binding sites on Ume6p has not been
characterized. Thus, the binding of MBP-Ume6p to UASPHR1
and SPO13 URS1 could occur at different, distinct sites on the
protein. To address this question, we examined the ability of
SPO13 URS1 and the DRC elements to compete for binding
FIG. 5. Electrophoretic mobility shift assays demonstrating the affinity and
specificity of MBP-Ume6p binding to UASPHR1 and SPO13 URS1. Assays were
performed as described in Materials and Methods with 10 nM labeled RIUAS
(A) or SPO13 URS1 (B) oligonucleotide, 80 nM MBP-Ume6p or purified MBP,
and various concentrations of either homologous or heterologous unlabeled
competitor oligonucleotide. Lanes: 1, labeled oligonucleotide only; 2, labeled
oligonucleotide plus purified MBP; 3 to 8, labeled oligonucleotide plus MBP-
Ume6p and 0, 10, 20, 50, 150, or 500 nM, respectively, unlabeled homologous
(RIUAS or SPO13 URS1) oligonucleotide; 9 to 14, labeled oligonucleotide plus
MBP-Ume6p and 0, 10, 20, 50, 150, or 500 nM, respectively, unlabeled heterol-
ogous (MIXUAS) oligonucleotide. Scanning of the autoradiogram and image
production were as described in the legend to Fig. 4.
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of MBP-Ume6p to UASPHR1. As can be seen in Fig. 7, the
SPO13 URS1 oligonucleotide competed efficiently with
UASPHR1 oligonucleotide for MBP-Ume6p binding. New
complexes, which might reflect simultaneous binding of the
two different oligonucleotides, were not observed. Consistent
with the KAs reported above, SPO13 URS1 and UASPHR1 were
similarly effective as competitors for Ume6p binding. Similar
results were obtained when DRC elements from RAD2, RAD7,
and RAD53 were used as competitors (Fig. 7). As expected
from the results obtained in the direct binding experiments,
MAG URS2 competed significantly less well than the other
regulatory elements despite the fact that it has 92% sequence
identity with the DRC consensus sequence (Fig. 6B). It may be
significant that MAG URS2 contains a G at position 10 of the
DRC homology region, while all other DRC elements possess
an A at this position.
Mutations in UASPHR1 reduce Ume6p binding and UME6-
dependent activation. If the in vitro binding of Ume6p reflects
a physiologically significant interaction, then mutations in
UASPHR1 that reduce Ume6p binding might also be expected
to reduce expression of the reporter in vivo. As an initial test
of this hypothesis, we constructed plasmids in which all of the
CGA elements in UASPHR1 had been either deleted or mu-
tated, as well as a plasmid in which the two GAAG elements
that form part of the conserved core of the DRC elements
were mutated. The CGA elements were targeted because they
correspond to the CGPu general consensus for sites bound by
FIG. 6. (A) Electrophoretic mobility shift assays demonstrating the affinity
and specificity of MBP-Ume6p for oligonucleotides containing DRC elements
from PHR1, SPO13, MAG, RAD2, RAD7, and RAD53. Assays were performed as
described in the legend to Fig. 5. Labeled oligonucleotides (oligo) were present
at 80 nM and were as indicated. Lanes 1 and 14, purified MBP present at 260 nM.
All other lanes contain MBP-Ume6p at 80 nM. Lanes 3, 7, 11, 16, 20, and 24,
homologous unlabeled competitor at 240 nM; lanes 4, 8, 12, 17, 21, and 25,
MIXUAS competitor at 240 nM; lanes 5, 9, 13, 18, 22, and 26, MIXUAS
competitor at 1200 nM. Scanning of the autoradiogram and image production
were as described in the legend to Fig. 4. (B) Alignment of the DRC sequences
present in the oligonucleotide probes and comparison to the URS1 and DRC
consensus sequences.
FIG. 7. Electrophoretic mobility shift assay demonstrating that SPO13 URS1
and various DRC elements compete with UASPHR1 oligonucleotide for binding
of MBP-Ume6p. Assays were performed as described in Materials and Methods
with RIUAS oligonucleotide at 80 nM as the labeled substrate. Lane 1, 260 nM
purified MBP. All other lanes contain 80 nM MBP-UME6p. Lane 2, RIUAS and
MBP-Ume6p only; lanes 3, 5, 7, 9, 11, and 13, 120 nM indicated competitor
oligonucleotide; lanes 4, 6, 8, 10, 12, and 14, 560 nM indicated competitor
oligonucleotide. Scanning of the autoradiogram and image production were as
described in the legend to Fig. 4.
TABLE 4. Competition of Ume6p-DNA complexes with
homologous and MIXUAS oligonucleotides
Labeled probe
(80 nM)





240 nM 1,200 nM
RIUAS 0.20 0.64 0.22
SPO13 0.42 0.68 0.46
MAGURS2 0.39 0.50 0.12
RAD2 0.27 0.78 0.33
RAD7 0.36 0.77 0.27
RAD53 0.21 0.67 0.12
a Relative to bound counts in the absence of competitor.
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fungal zinc binuclear cluster proteins (9). We chose to change
multiple copies of the elements simultaneously because previ-
ous studies indicated that deletion or mutation of a single
CGA or GAAG element had only a marginal effect on expres-
sion (47). Mutation of the three CGA elements reduced
Ume6p binding in vitro by 40% as measured in binding com-
petition assays, while deletion of the elements reduced binding
by 70% (Table 5). In contrast, mutation of the GAAG ele-
ments had no effect on Ume6p binding. Due to the high non-
specific binding of Ume6p, complete elimination of the se-
quences specifically recognized by Ume6p is expected to
decrease binding by no more than 90 to 95% in our in vitro
assays. Therefore, the results suggest that the CGA sequences
(or portions thereof) comprise a portion of the Ume6p recog-
nition sequence. In vivo expression studies revealed that in the
presence of UME6, both deletion and mutation of the CGA
elements reduced the induction ratio (i.e., the level of expres-
sion in late log phase relative to that in early log phase) ap-
proximately twofold compared to that with the intact UAS;
however, neither of these elements reduced basal-level expres-
sion. (Deletion of the CGA elements led to approximately
twofold-greater basal-level expression. This increase is proba-
bly due to a nonspecific “spacing effect,” since it was seen in six
independent transformants [data not shown] and in both the
presence and absence of UME6.) Deletion of UME6 further
reduced basal-level and induced expression from both con-
structs containing altered CGA elements. These results are
consistent with either of two interpretations: (i) interaction of
Ume6p with UASPHR1 is mediated both through DNA con-
tacts and through interaction with one or more additional
proteins bound to the UAS, or (ii) UME6 regulates expression
from UASPHR1 via two mechanisms, only one of which involves
direct interaction between Ume6p and the UAS.
Mutation of the GAAG elements had unexpected effects: in
the presence of UME6, basal-level expression increased five-
fold and the induction ratio decreased to 25% of that seen with
the intact UAS. Inactivation of UME6 did not substantially
affect expression from this mutant GAAG UAS. We believe
that the results obtained with the mutant GAAG UAS are due
to the fortuitous introduction of a new, Ume6-insensitive ac-
tivator binding site. An alternative explanation is that the
GAAG elements bind a repressor the activity of which is neg-
atively regulated by UME6; however, this would not explain the
correlation between decreased Ume6p binding and decreased
induction observed when the CGA elements are modified.
Effect of a UME6 deletion on UV sensitivity and photoreac-
tivation. The results presented above indicate that UME6 en-
hances expression of PHR1 and may also contribute to the
regulated expression of other DRC-containing genes. Accord-
ing to this model, a ume6 deletion strain would be expected to
exhibit reduced photoreactivation and perhaps also reduced
survival in the absence of photoreactivation (dark survival).
The UV survival data shown in Fig. 8 for late-log-phase GBS77
(UME6) and its isogenic derivative GBS1072 (Dume6) confirm
this prediction. At all UV fluences tested, the absence of a
functional UME6 gene resulted in increased UV sensitivity
(Fig. 8A). To determine the effect on photoreactivation, cells
irradiated at various 254-nm fluences were exposed to a limit-
ing fluence of photoreactivating light for 5 min. At all UV
fluences of $2 J/m2, GBS1072 (Dume6) displayed reduced
dimer photorepair compared to GBS77 (UME6), consistent
with a reduction in the steady-state concentration of active
photolyase molecules (Fig. 8). From the data shown in Fig. 8A
and similar experiments, we estimate that at 4 J/m2, DD is 1.5
J/m2 for GBS77 and 0.9 J/m2 for GBS1072, which corresponds
to photoreactivation of 360 dimers in the former strain and 240
dimers in the latter strain. This is a much smaller change in
photoreactivation than might be predicted from the b-galac-
tosidase data shown in Fig. 3. Several factors contribute to this
difference: (i) it is clear from the slopes of the curves in Fig. 8B
that substrate saturation was not reached, and this would
lead to underestimation of the number of photolyase mol-
ecules; (ii) the b-galactosidase experiments measure the activ-
ity of UASPHR1 in the absence of other regulatory elements
which may attenuate the response of the intact PHR1 pro-
moter; and (iii) at low b-galactosidase concentrations a small
increase in the concentration of monomers may produce a
large increase in the number of active tetramers. The differ-
ence in photoreactivation produced by deletion of ume6 is
significant in light of previous studies which have shown that
the number of photolyase molecules per cell is approximately
twofold greater in stationary-phase S. cerevisiae cells than in
log-phase cells (69). Our results indicate that a significant
portion of this increase is UME6 dependent.
DISCUSSION
The results reported in this study indicate that UME6 is a
positive regulator of PHR1 transcription which acts through
UASPHR1. Several lines of evidence support this conclusion.
Multiple copies of UME6 enhance expression from both
UASPHR1 and the intact PHR1 promoter in its normal chro-
mosomal context. Deletion of UME6 abolishes induction from
UASPHR1 and from the intact promoter in late log phase. An
MBP-Ume6p fusion protein containing the Ume6p DNA bind-
ing domain displays sequence-specific binding to UASPHR1,
TABLE 5. Effect of mutations in UASPHR1 on expression in UME6 and Dume6 backgrounds
UASPHR1a Sequenceb KA (107) Strain Genotype
b-Galactosidase activity (U)c Induction
ratiodA600 , 0.25 A600 . 1.0
Intact 59CTTTTCTTCCTCGTTTTTCGAGGAAGCAGT39 1.4 GBS1330 UME6 2,400 (190) 13,800 (500) 5.8
39GAAAAGAAGGAGCAAAAAGCTCCTTCGTCA59 GBS1353 Dume6 850 (170) 780 (130) 1.0
DCGA 59CTTTTCTTCC–––TTTTT–––GGAAGCAGT39 0.4 GBS1333 UME6 4,500 (140) 14,700 (1,500) 3.3
39GAAAAGAAGG–––AAAAA–––CCTTCGTCA59 GBS1351 Dume6 1,800 (230) 2,400 (330) 1.3
mCGA 59CTTTTCTTCCACTTTTTACGTGGAAGCAGT39 0.8 GBS1336 UME6 2,790 (190) 7,300 (310) 2.6
39GAAAAGAAGGTGAAAAATGCACCTTCGTCA59 GBS1358 Dume6 900 (180) 900 (90) 1.0
mGAAG 59CTTTTTGCACTCGTTTTTCGACACAGCAGT39 1.3 GBS1339 UME6 16,800 (1,500) 24,000 (2,500) 1.4
39GAAAAACGTGAGCAAAAAGCTGTGTCGTCA59 GBS1361 Dume6 16,500 (1,800) 16,800 (2,300) 1.0
a m, mutant.
b Deletions are indicated by dashes; base replacements are underlined.
c Averages of three independent determinations with standard deviations shown in parentheses.
d b-Galactosidase units at an A600 of .1.0 divided by units at an A600 of ,0.25.
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and alterations in the UAS that reduce Ume6p binding reduce
expression in vivo. The most parsimonious explanation for
these observations is that Ume6p exerts its effects in vivo by
binding directly to UASPHR1. We wish to emphasize that
UME6 is not required for basal-level expression of PHR1 in
early log phase but rather enhances basal-level expression.
This is indicated by the observation that deletion of UME6
reduces expression from UASPHR1 by no more than 70% dur-
ing early-log-phase growth, and the same low level of UAS
activity is maintained during later stages of growth in the ab-
sence of functional Ume6p. Thus, there must be additional
proteins that bind to and activate UASPHR1. Given the small
size of this region (29 bp), it is likely that Ume6p interacts with
them.
Ume6p is a 91-kDa transcriptional regulator that contains a
Zn2Cys6 binuclear cluster (1, 59) and is thus formally similar to
other fungal binuclear transcriptional regulatory proteins, such
as Gal4p, Ppr1p, and Hap1p (33, 34, 44). These proteins gen-
erally bind as homodimers to CGPu sequences arranged as
molecular palindromes, direct repeats, or everted repeats, with
the spacing between elements of the recognition sequence
determined by a spacer region immediately following the binu-
clear cluster (reviewed in references 34 and 70). The spacer
region is in turn followed by leucine-rich heptads which form
the dimerization interface. Ume6p is an atypical member of
this class in that it lacks the linker domain and leucine-rich
dimerization domain and appears to bind DNA as a monomer
(1). Circular dichroism studies indicate that in solution Ume6p
has little stable secondary structure outside the helices imme-
diately surrounding the binuclear zinc cluster, suggesting that
interactions with other transcriptional regulatory proteins may
control Ume6p folding (1). This may be similar to the situation
recently reported for the Cdk inhibitor p21, which is largely
disordered in solution but becomes highly ordered upon asso-
ciation with cyclin-Cdk complexes (26). Conformational flexi-
bility may be directly relevant to the diversity of Ume6p func-
tion implied by our results.
UME6 regulates expression of a diverse group of genes in-
volved in numerous metabolic pathways, including most of the
early meiotic genes, HSP82, INO1, FOX3, and CAR1 (10, 19,
39, 61). Deletion of UME6 increases transcription of each of
these genes during vegetative growth; thus, UME6 formally
functions as a repressor in these promoter contexts. These
observations are in marked contrast to the role of UME6 as an
activator of PHR1 expression during vegetative growth. Our
results eliminate IME1, the UME6-dependent transcriptional
activator of early meiotic genes (3, 45), as a required partici-
pant in activation of the UAS. However, our observation that
mutations that strongly affect Ume6p binding in vitro have
much smaller effects on expression in vivo are consistent with
a role for protein-protein interactions in recruitment of
Ume6p to the UAS. Sequence context differences have been
proposed to explain differential requirements for Sin3p in
Ume6p-mediated repression. Ume6p recruits the transcrip-
tional corepressors Sin3 and Rpd3 to the IME2 and INO1
URS1 elements (21); however, URS1 elements from TRK2
and CAR1, when placed in the context of the CYC1 promoter,
do not require Sin3 to mediate repression (42, 66). Perhaps
sequence-induced changes in Ume6p structure play a role in
determining interacting partners, as has been shown for Oct-1
(8, 38), or reveal an activation domain, as proposed for Mcm1p
(63).
The URS1 element has the consensus sequence TAGCCG
CCGA, and purified Ume6p protects the repeated CCG se-
quences from DNase I digestion (1). UASPHR1 does not con-
tain a good match to either the URS1 sequence or the CCG
motif, yet Ume6p binds UASPHR1 with an affinity and a spec-
ificity similar to those for the URS1 site in SPO13. Our results
strongly suggest that a related sequence, CGA, which matches
the general consensus CGPu for fungal zinc binuclear cluster
proteins (9), forms a part of the Ume6p binding site in
UASPHR1. We have not explored the sequence requirements
for Ume6p binding to any of the other DRC-containing ele-
ments tested here; however, it is clear that Ume6p must rec-
ognize sequences in addition to CGA and CCG, because the
RAD7 oligonucleotide used in these studies does not contain
either sequence but is strongly bound by Ume6p. The crystal
structures and solution structures of the zinc binuclear cluster
proteins Gal4p, Ppr1p, and Lac9p indicate that the zinc cluster
is usually compact and quite rigid (14, 33, 34). Nevertheless,
this structure is sufficiently flexible to permit Hap1p to bind to
both CGG and CGC triplets in the CYC1 and CYC7 promot-
FIG. 8. UV survival and pyrimidine dimer repair in strains GBS77 (UME6)
(circles) and GBS1072 (Dume6) (triangles). The strains were cultured, exposed
to 254-nm radiation, and subsequently incubated in the dark either without
(closed symbols) or with (open symbols) a 5-min period of photoreactivation as
described in Materials and Methods. (A) Survival curves. (B) Number of pyrim-
idine dimers repaired during the 5-min photoreactivation period, calculated as
described in Materials and Methods.
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ers, respectively (70). Our results suggest similar flexibility in
Ume6p binding site selection.
The specificity of Ume6p binding is quite low for a se-
quence-specific DNA binding protein. We find that the equi-
librium association constant (KA) for interaction of MBP-
Ume6p with URS1SPO13 is only about 20-fold greater than that
for a nonspecific oligonucleotide competitor of the same
length. It is unlikely that this is an artifact introduced by use of
a truncated fusion protein, because MBP alone does not bind
the oligonucleotide with measurable affinity (this study), and
the observed KA for the fusion protein is only about fourfold
lower than that reported for the interaction of full-length
Ume6p with URS1SPO13 (1). While estimates of nonspecific
binding for full-length Ume6p have not been reported, a close
examination of Fig. 6 in reference 1 suggests that at physio-
logical salt concentrations the ratio of specific to nonspecific
binding is within an order of magnitude of the value reported
here. This low discrimination ratio predicts that in vivo,
Ume6p could not efficiently find its cognate binding sites amid
an excess of nonspecific binding sites. Possibly Ume6p is tar-
geted to its binding sites in vivo via interactions with proteins
that confer increased (and perhaps in some cases altered)
binding specificity. The following circumstantial evidence sug-
gests that RP-A may be such a Ume6p-interacting protein. (i)
UME6 is required for repression at URS1CAR1, and RP-A,
either purified or in crude extracts, binds specifically to this site
(28, 29, 42). Comparable results have been reported for a
URS1 site in the FOX3 promoter (10). (ii) Crude extracts from
Dume6 strains display some differences in the pattern of
URS1CAR1–RP-A complexes (42). Similar changes have in the
spectrum of complexes formed on the URS1SPO13 have been
noted, although the direct involvement of RP-A has not been
demonstrated (59). (iii) RP-A binds to sequences from the 59
regulatory regions of at least 12 yeast genes involved in DNA
repair and DNA metabolism, including UASPHR1 (55).
The UME6-dependent regulation of PHR1 expression in re-
sponse to growth cycle stage provides a mechanistic basis for
earlier observations (69) that the number of active photolyase
molecules is approximately twofold greater in stationary-phase
cells than in log-phase cells. Induction of PHR1 in late log
phase coincides with the onset of glycogen accumulation that
immediately precedes the switch from fermentative to oxida-
tive carbon metabolism. The precise regulatory circuitry con-
trolling this metabolic change, known as the diauxic shift, re-
mains to be elucidated; however, it is clear that transcriptional
and posttranslational processes are involved and that these
processes are regulated, at least in part, through the RAS/
cAMP/A-kinase and SNF1 signal transduction pathways (5, 16,
64). Our results indicate that UME6 directly links PHR1 ex-
pression to the nutritional status of the cell. The level of UME6
mRNA does not vary with nutritional status or during sporu-
lation (59), and it is presumed that the same is true for Ume6p.
Thus, the UME6-dependent activation of UASPHR1 probably
depends upon modification of Ume6p or other proteins at the
UAS. A mechanism is immediately suggested by the fact that
Ume6p contains four consensus sites for phosphorylation by
cAMP-dependent protein kinase (59).
The potential regulation of PHR1 by cAMP levels is remi-
niscent of the regulation of certain multistress-responsive
genes in yeast and mammals. In S. cerevisiae, transcription of
the multistress response genes UBI4, CTT1, SSA3, HSP12, and
TPS2 is negatively regulated by cAMP levels via a common
STRE that is the binding site for the transcriptional activator
Msn2p (2, 35, 49). In fission yeast the multistress response
pathway is controlled by a different transcription factor, Atf1,
that in vitro binds specifically to ATF/CRE sites that confer
cAMP responsiveness (52, 62). Furthermore, like UME6, atf11
regulates the expression of a meiosis-specific transcription reg-
ulator (52, 57). Despite these similarities, the response of
PHR1 to UV and to nutritional status is clearly different from
the general stress response. Unlike components of the multi-
stress response, PHR1 is not induced by heat shock (50), and
there is not a match to the STRE or ATF/CRE consensus
sequence within UASPHR1. A further difference pertains to the
integration of the nutritional and UV responses. In the PHR1
promoter, the nutritional response is conferred by UASPHR1-
Ume6p, whereas the response to UV and other DNA-damag-
ing agents is controlled primarily through an upstream repres-
sor element and the damage-responsive repressor Prp (47, 51).
In contrast, Msn2 and Atf1 are required for both the UV
response and the nutritional response of the multistress re-
sponse genes (32, 35, 49).
Understanding the mechanism through which UME6 medi-
ates induction of PHR1 will likely require elucidation of the
roles of the RAS/A-kinase and SNF1 signal transduction path-
ways in this process as well as identification of proteins that
interact with Ume6p at UASPHR1. In addition, the role of
UME6 in regulating expression of other DNA repair genes
remains to be definitively addressed. It may be significant that
the majority of damage-responsive genes in yeast are also in-
duced early in meiosis (see reference 13 and references there-
in), at approximately the same time as the known UME6-
dependent early meiotic genes (39). Finally, our results
indicate that both the sequences recognized by Ume6p and the
physiological consequences of Ume6p binding are more di-
verse than has been previously recognized.
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